(-)-demecolcine decreases expression ISO CBX5 (Homo sapiens) 6480464 Demecolcine results in decreased expression of CBX5 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Cbx5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CBX5 mRNA CTD PMID:36331819 (S)-nicotine multiple interactions ISO Cbx5 (Mus musculus) 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dichloroethane decreases expression ISO Cbx5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CBX5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Cbx5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CBX5 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Cbx5 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Cbx5 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Cbx5 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CBX5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CBX5 mRNA CTD PMID:33387578 and PMID:34747641 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of CBX5 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO Cbx5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CBX5 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO CBX5 (Homo sapiens) 6480464 bisphenol S results in increased expression of CBX5 protein CTD PMID:34186270 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CBX5 mRNA CTD PMID:30047161 all-trans-retinoic acid decreases expression ISO CBX5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CBX5 protein CTD PMID:16569592 and PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of CBX5 mRNA CTD PMID:30047161 atrazine increases expression ISO CBX5 (Homo sapiens) 6480464 Atrazine results in increased expression of CBX5 mRNA CTD PMID:22378314 benzatropine multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of CBX5 protein CTD PMID:34122009 benzo[a]pyrene increases expression ISO CBX5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CBX5 mRNA CTD PMID:21632981 benzo[a]pyrene increases methylation ISO CBX5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CBX5 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO CBX5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 and PMID:20382639 bisphenol A increases expression ISO Cbx5 (Mus musculus) 6480464 bisphenol A results in increased expression of CBX5 mRNA CTD PMID:22687993 bisphenol A decreases expression ISO CBX5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CBX5 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CBX5 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CBX5 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO CBX5 (Homo sapiens) 6480464 bisphenol B results in increased expression of CBX5 protein CTD PMID:34186270 butanal decreases expression ISO CBX5 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of CBX5 mRNA CTD PMID:26079696 butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of CBX5 protein CTD PMID:23535288 caffeine multiple interactions ISO Cbx5 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 carbon nanotube decreases expression ISO Cbx5 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CBX5 mRNA CTD PMID:25620056 chlorpyrifos decreases expression ISO Cbx5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of CBX5 mRNA CTD PMID:37019170 cisplatin multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CBX5 mRNA CTD PMID:27392435 cisplatin decreases expression ISO CBX5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of CBX5 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO CBX5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CBX5 mRNA CTD PMID:19320972 and PMID:19376846 copper atom multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of CBX5 mRNA CTD PMID:20971185 copper atom multiple interactions ISO Cbx5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CBX5 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of CBX5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO Cbx5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CBX5 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO CBX5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CBX5 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA CTD PMID:19167446 coumestrol increases expression ISO CBX5 (Homo sapiens) 6480464 Coumestrol results in increased expression of CBX5 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO Cbx5 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CBX5 mRNA CTD PMID:29279043 Cuprizon multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of CBX5 protein and [Cuprizone co-treated with Haloperidol] results in increased expression of CBX5 protein CTD PMID:34122009 cyclosporin A decreases expression ISO CBX5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CBX5 mRNA CTD PMID:20106945 deoxynivalenol increases phosphorylation ISO Cbx5 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of CBX5 protein CTD PMID:23811945 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CBX5 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO CBX5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CBX5 mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO CBX5 (Homo sapiens) 6480464 Selenium results in decreased expression of CBX5 mRNA CTD PMID:19244175 entinostat decreases expression ISO CBX5 (Homo sapiens) 6480464 entinostat results in decreased expression of CBX5 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CBX5 protein CTD PMID:23301498 ethanol decreases expression ISO CBX5 (Homo sapiens) 6480464 Ethanol results in decreased expression of CBX5 mRNA CTD PMID:28986285 fenbendazole increases expression EXP 6480464 Fenbendazole results in increased expression of CBX5 protein CTD PMID:23411599 formaldehyde decreases expression ISO CBX5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CBX5 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO CBX5 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of CBX5 protein CTD PMID:37730182 genistein increases expression ISO CBX5 (Homo sapiens) 6480464 Genistein results in increased expression of CBX5 protein CTD PMID:20884965 genistein multiple interactions ISO CBX5 (Homo sapiens) 6480464 ESR2 promotes the reaction [Genistein results in increased expression of CBX5 protein] CTD PMID:20884965 haloperidol multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of CBX5 protein CTD PMID:34122009 hydrogen peroxide affects expression ISO CBX5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CBX5 mRNA CTD PMID:21179406 ivermectin decreases expression ISO CBX5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of CBX5 protein CTD PMID:32959892 leflunomide increases expression ISO CBX5 (Homo sapiens) 6480464 leflunomide results in increased expression of CBX5 mRNA CTD PMID:28988120 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CBX5 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO CBX5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CBX5 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO CBX5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of CBX5 mRNA CTD PMID:28001369 methylparaben decreases expression ISO CBX5 (Homo sapiens) 6480464 methylparaben results in decreased expression of CBX5 mRNA CTD PMID:31745603 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO CBX5 (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in decreased expression of CBX5 mRNA CTD PMID:12634122 N-nitrosodiethylamine multiple interactions ISO Cbx5 (Mus musculus) 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CBX5 mRNA] CTD PMID:17854601 N-nitrosodiethylamine increases expression ISO Cbx5 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CBX5 mRNA CTD PMID:17854601 nicotine multiple interactions ISO Cbx5 (Mus musculus) 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of CBX5 protein CTD PMID:23411599 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CBX5 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CBX5 mRNA CTD PMID:25729387 ozone multiple interactions ISO Cbx5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CBX5 mRNA CTD PMID:34911549 ozone multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of CBX5 mRNA CTD PMID:35430440 p-chloromercuribenzoic acid decreases expression ISO CBX5 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of CBX5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBX5 mRNA CTD PMID:27188386 paracetamol affects expression ISO Cbx5 (Mus musculus) 6480464 Acetaminophen affects the expression of CBX5 mRNA CTD PMID:17562736 paracetamol increases expression ISO CBX5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CBX5 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid increases expression ISO Cbx5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of CBX5 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO Cbx5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CBX5 mRNA CTD PMID:36331819 phenethyl isothiocyanate decreases expression ISO CBX5 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of CBX5 mRNA CTD PMID:26678675 phenylmercury acetate decreases expression ISO CBX5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of CBX5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBX5 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Cbx5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CBX5 mRNA CTD PMID:17426115 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CBX5 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CBX5 mRNA CTD PMID:19162173 and PMID:30047161 quercetin increases expression ISO CBX5 (Homo sapiens) 6480464 Quercetin results in increased expression of CBX5 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO CBX5 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 selenium atom multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA CTD PMID:19244175 selenium atom decreases expression ISO CBX5 (Homo sapiens) 6480464 Selenium results in decreased expression of CBX5 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO CBX5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CBX5 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO CBX5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CBX5 mRNA CTD PMID:17879257 sodium arsenite increases expression ISO CBX5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CBX5 mRNA CTD PMID:28595984 and PMID:34032870 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CBX5 mRNA CTD PMID:30047161 sunitinib decreases expression ISO CBX5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CBX5 mRNA CTD PMID:31533062 testosterone enanthate affects expression ISO CBX5 (Homo sapiens) 6480464 testosterone enanthate affects the expression of CBX5 mRNA CTD PMID:17440010 thimerosal decreases expression ISO CBX5 (Homo sapiens) 6480464 Thimerosal results in decreased expression of CBX5 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CBX5 protein CTD PMID:23411599 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CBX5 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO CBX5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of CBX5 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBX5 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO Cbx5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CBX5 mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CBX5 mRNA CTD PMID:30589522 troglitazone decreases expression ISO Cbx5 (Mus musculus) 6480464 troglitazone results in decreased expression of CBX5 mRNA CTD PMID:28973697 urethane decreases expression ISO CBX5 (Homo sapiens) 6480464 Urethane results in decreased expression of CBX5 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO CBX5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBX5 mRNA CTD PMID:27188386 valproic acid decreases expression ISO CBX5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CBX5 mRNA CTD PMID:23179753 more ... vincristine decreases expression ISO CBX5 (Homo sapiens) 6480464 Vincristine results in decreased expression of CBX5 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO CBX5 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA CTD PMID:19244175 vitamin E decreases expression ISO CBX5 (Homo sapiens) 6480464 Vitamin E results in decreased expression of CBX5 mRNA CTD PMID:19244175 vorinostat increases expression ISO CBX5 (Homo sapiens) 6480464 vorinostat results in increased expression of CBX5 protein CTD PMID:20543569 vorinostat decreases expression ISO CBX5 (Homo sapiens) 6480464 vorinostat results in decreased expression of CBX5 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO CBX5 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CBX5 mRNA CTD PMID:20977926
